These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16245958)

  • 21. Published randomized controlled trials of drug therapy for dementia often lack complete data on harm.
    Lee PE; Fischer HD; Rochon PA; Gill SS; Herrmann N; Bell CM; Sykora K; Anderson GM
    J Clin Epidemiol; 2008 Nov; 61(11):1152-60. PubMed ID: 18619812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?
    Trifirò G; Spina E; Gambassi G
    Pharmacol Res; 2009 Jan; 59(1):1-12. PubMed ID: 18977443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    Derry S; Moore RA
    BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Sink KM; Holden KF; Yaffe K
    JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do atypical antipsychotics cause stroke?
    Herrmann N; Lanctôt KL
    CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
    Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
    JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
    Yury CA; Fisher JE
    Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review.
    Yeh YC; Ouyang WC
    Kaohsiung J Med Sci; 2012 Apr; 28(4):185-93. PubMed ID: 22453066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia Among Community Dwelling Adults.
    Trinkley KE; Sturm AM; Porter K; Nahata MC
    J Pharm Pract; 2020 Feb; 33(1):7-14. PubMed ID: 29695193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis.
    Watt JA; Goodarzi Z; Veroniki AA; Nincic V; Khan PA; Ghassemi M; Thompson Y; Lai Y; Treister V; Tricco AC; Straus SE
    BMC Geriatr; 2020 Jun; 20(1):212. PubMed ID: 32546202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
    Gurevich A; Guller V; Berner YN; Tal S
    J Nutr Health Aging; 2012; 16(6):557-61. PubMed ID: 22659997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia.
    Dyer SM; Harrison SL; Laver K; Whitehead C; Crotty M
    Int Psychogeriatr; 2018 Mar; 30(3):295-309. PubMed ID: 29143695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.
    Gallini A; Andrieu S; Donohue JM; Oumouhou N; Lapeyre-Mestre M; Gardette V
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):95-104. PubMed ID: 24126116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    Jin B; Liu H
    J Neurol; 2019 Oct; 266(10):2363-2375. PubMed ID: 30666436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'He was like a zombie': off-label prescription of antipsychotic drugs in dementia.
    Harding R; Peel E
    Med Law Rev; 2013 Mar; 21(2):243-77. PubMed ID: 23047844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsants for behavioral and psychological symptoms in dementia: protocol for a systematic review.
    Benjamin S; Williams JW; Cotton C; Tung J; An H; Sanger S; Ho JM
    Syst Rev; 2019 May; 8(1):118. PubMed ID: 31103045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.
    Gentile S
    Psychopharmacology (Berl); 2010 Oct; 212(2):119-29. PubMed ID: 20661553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nursing mentoring programme on non-pharmacological interventions against BPSD: Effectiveness and use of antipsychotics-A retrospective, before-after study.
    Plante-Lepage R; Voyer P; Carmichael PH; Kröger E
    Nurs Open; 2022 Jan; 9(1):181-188. PubMed ID: 34612586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.